About: covid:PMC7316575

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7316575 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Mitchell, Ellen Scott, Cherise Blatner, G. Gelderbloem, S. Hawkridge, T. Kaguthi, G. Laserson, K. Nduba, V. Okelloh, D. Ouma, S. Rabuogi, P. Richardus, J. Verver, S. de Steenwinkel, J.
is schema:about of	named entity 'AFRICA' named entity 'EBOLA' named entity 'DEVELOPMENT' named entity 'Ebola' named entity 'Africa' named entity 'preclinical phases' named entity 'placebo' named entity 'immunogenicity' named entity 'demographic surveillance' named entity 'small pox' named entity 'community mobilization' named entity 'Nairobi' named entity 'epidemiological studies' named entity 'Mycobacterium tuberculosis' named entity 'National Institutes of Health' named entity 'research methods' named entity 'epidemic' named entity 'social class' named entity 'human trials' named entity 'Tuberculosis Vaccine' named entity 'Pediatric' named entity 'reference ranges' named entity 'vaccine' named entity 'ethics' named entity 'Uganda' named entity 'stage gate' named entity '2014-2016' named entity 'phase III trial' named entity 'Health research' named entity 'research teams' named entity 'epidemiological data' named entity 'placebo' named entity 'human disease' named entity 'epidemiological studies' named entity 'HDSS' named entity 'HDSS' named entity 'Clinical Research' named entity 'scientific framework' named entity 'Ebola' named entity 'return on investment' named entity 'vaccine' named entity 'Ebola virus' named entity 'clinical research sites' named entity 'vaccines' named entity 'Vienna' named entity 'World Health Organization' named entity 'vaccine' named entity 'vaccine' named entity 'traditional birth attendant' named entity 'vaccine' named entity 'South Africa' named entity 'immunogenicity' named entity 'West Africa' named entity 'epidemic' named entity 'pathogen' named entity 'radiography' named entity 'Ebola' named entity 'Clinical trial' named entity 'vaccine' named entity 'immunology' named entity 'vaccine' named entity 'Ebola vaccine' named entity 'Mozambique' named entity 'chest radiograph' named entity 'pediatric ward' named entity 'Kenya' named entity 'pre-clinical development' named entity 'malaria' named entity 'immunology' named entity 'epidemiological' named entity 'WHO' named entity 'HIV' named entity 'immunization' named entity 'vaccinating' named entity 'vaccine' named entity 'sputum' named entity 'Phase IIb' named entity 'NIH' named entity 'follow-up' named entity 'PBMC' named entity 'RTS,S' named entity 'Personal Digital Assistants' named entity 'Ebola' named entity 'BCG' named entity 'median age' named entity 'HIV'

Attributes

Values

Creator

Mitchell, Ellen
Scott, Cherise
Blatner, G.
Gelderbloem, S.
Hawkridge, T.
Kaguthi, G.
Laserson, K.
Nduba, V.
Okelloh, D.
Ouma, S.
Rabuogi, P.
Richardus, J.
Verver, S.
de Steenwinkel, J.

is schema:about of

named entity 'AFRICA'
named entity 'EBOLA'
named entity 'DEVELOPMENT'
named entity 'Ebola'
named entity 'Africa'
named entity 'preclinical phases'
named entity 'placebo'
named entity 'immunogenicity'
named entity 'demographic surveillance'
named entity 'small pox'
named entity 'community mobilization'
named entity 'Nairobi'
named entity 'epidemiological studies'
named entity 'Mycobacterium tuberculosis'
named entity 'National Institutes of Health'
named entity 'research methods'
named entity 'epidemic'
named entity 'social class'
named entity 'human trials'
named entity 'Tuberculosis Vaccine'
named entity 'Pediatric'
named entity 'reference ranges'
named entity 'vaccine'
named entity 'ethics'
named entity 'Uganda'
named entity 'stage gate'
named entity '2014-2016'
named entity 'phase III trial'
named entity 'Health research'
named entity 'research teams'
named entity 'epidemiological data'
named entity 'placebo'
named entity 'human disease'
named entity 'epidemiological studies'
named entity 'HDSS'
named entity 'HDSS'
named entity 'Clinical Research'
named entity 'scientific framework'
named entity 'Ebola'
named entity 'return on investment'
named entity 'vaccine'
named entity 'Ebola virus'
named entity 'clinical research sites'
named entity 'vaccines'
named entity 'Vienna'
named entity 'World Health Organization'
named entity 'vaccine'
named entity 'vaccine'
named entity 'traditional birth attendant'
named entity 'vaccine'
named entity 'South Africa'
named entity 'immunogenicity'
named entity 'West Africa'
named entity 'epidemic'
named entity 'pathogen'
named entity 'radiography'
named entity 'Ebola'
named entity 'Clinical trial'
named entity 'vaccine'
named entity 'immunology'
named entity 'vaccine'
named entity 'Ebola vaccine'
named entity 'Mozambique'
named entity 'chest radiograph'
named entity 'pediatric ward'
named entity 'Kenya'
named entity 'pre-clinical development'
named entity 'malaria'
named entity 'immunology'
named entity 'epidemiological'
named entity 'WHO'
named entity 'HIV'
named entity 'immunization'
named entity 'vaccinating'
named entity 'vaccine'
named entity 'sputum'
named entity 'Phase IIb'
named entity 'NIH'
named entity 'follow-up'
named entity 'PBMC'
named entity 'RTS,S'
named entity 'Personal Digital Assistants'
named entity 'Ebola'
named entity 'BCG'
named entity 'median age'
named entity 'HIV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software